2021•PubMedRequires access

Fewer Subsequent Strokes with Ticagrelor Plus Aspirin than with Aspirin Alone.

Nita Shrikant Kulkarni

Open publisher page 0 citations

Abstract

For patients with mild to moderate acute nonembolic ischemic stroke, treatment with ticagrelor plus aspirin for 30 days resulted in fewer subsequent strokes but similar overall disability and an increase in severe bleeding compared with aspirin alone.

About this research paper

What this paper is about

For patients with mild to moderate acute nonembolic ischemic stroke, treatment with ticagrelor plus aspirin for 30 days resulted in fewer subsequent strokes but similar overall disability and an increase in severe bleeding compared with aspirin alone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

For patients with mild to moderate acute nonembolic ischemic stroke, treatment with ticagrelor plus aspirin for 30 days resulted in fewer subsequent strokes but similar overall disability and an increase in severe bleeding compared with aspirin alone.

Key concepts: Medicine, Ticagrelor, Aspirin, Stroke (engine), Internal medicine, Cardiology, Anesthesia, Clopidogrel

Related papers

Back to paper searchBrowse research topicsOriginal source
Fewer Subsequent Strokes with Ticagrelor Plus Aspirin than with Aspirin Alone. — Research Paper | ScholarLens